1. Introduction {#Section1}
===============

Selective lipid deposition in meat animals is a relatively new strategy for improving production efficiency while improving meat quality. Efforts of reducing lipid deposition include genetic/breeding selection, feeding strategies, housing and environmental strategies, and hormone supplementation [@B1]. While these efforts have improved production efficiency and reduced carcass lipid deposition, one negative impact is thought to be reduced meat quality because of reduced lipid deposition in muscle, also known as marbling fat [@B1]. Although there is growing interest in developing alternative technologies to alter lipid deposition to selectively enhance marbling fat in meat animals, the mechanisms leading to differential lipid accumulation in visceral, subcutaneous, intermuscular and intramuscular fat depots remain unclear [@B1], [@B2]. Selection of ruminant sires [@B3] and breeds of cattle (Wagyu and Angus) that have the potential to partition energy to muscle adipocytes early in the growth period in their offspring has shown promise in promoting marbling [@B4]. Studying the cellular development, metabolism, and regulatory mechanisms of various cell types in different anatomical adipose depots [@B1], [@B5] has also provided insight for selective lipid deposition. Research with meat animals may very well lead to a new understanding of the regulation of lipid metabolism and adipocyte physiology. In addition, increased understanding of ectopic lipid storage observed in humans will help our overall understanding of the complex process of lipid storage. Collectively, methods developed to modulate selective lipid deposition may serve the dual purpose of improving meat quality and animal husbandry and metabolic regulation in humans, with potential to impact human health, particularly in individuals with lipodystrophy and obesity with concomitant ectopic lipid storage.

2. Lipid metabolism in meat animals {#Section2}
===================================

Meat animals are either non-ruminants (pigs and poultry; poultry will not be considered here) and ruminants (cattle, sheep, goats). Non-ruminants possess a gastrointestinal tract anatomically and functionally similar to that of humans and rodents. Alternatively, ruminants possess a forestomach anaerobic fermentation system (rumen-reticulum), anterior to the gastric organ and intestines. In ruminants, the adipose tissue is the principal site of *de novo* fatty acid (FA) synthesis [@B6], [@B7], which is markedly different from de novo lipogenesis in non-ruminants which occurs in the liver. Smith and Crouse [@B8] found that in ruminants glucose is the favoured substrate for lipogenic adipocytes in muscle, unlike subcutaneous adipocytes where acetate is favoured. In corroboration, Pethick et al. [@B9] found that visual marbling fat was elevated in ruminants that were fed carbohydrate that had escaped rumen fermentation and was later digested into glucose units in the intestine. The extent of carbohydrate escape from rumen fermentation is dependent on feed processing and other factors, but beef cattle fed high starch-containing diets will have more glucose directly absorbed from the small intestine than forage-fed animals [@B10]. Lipid deposition is increased in skeletal muscle in humans when there is insulin resistance in other adipose tissue depots, and the energy-bearing carbon is redirected to skeletal muscle [@B11]. Thus, major meat animals like both pigs and ruminants exhibit patterns of lipid metabolism distinctly different from humans and rodents (Table [1](#T1){ref-type="table"}).

Lipid metabolism in non-ruminant animals
----------------------------------------

Non-ruminant farm animals such as pigs eat diets containing both carbohydrates and dietary fats. Typically, pigs are fed cereal grains (starch) and low amounts of fat. Monosaccharides and FAs are absorbed directly from the small intestine and monosaccharides arrive at the liver via the portal vein, while dietary FAs are incorporated into chylomicrons and transported to tissues via the lymphatic system and then into the general (blood) circulation. Any glucose not immediately metabolized (or in excess of energy needs) will be used for de novo FA synthesis and then triacylglycerol (TAG) storage in adipose tissue depots [@B6], [@B7]. Thus unlike in humans and rodents, this excess energy will not be immediately converted to FA, TAG and then very low density lipoproteins (VLDL) in the porcine liver [@B7]. Further in pigs fed low fat diets, hepatic VLDL synthesis will depend on FA available from adipose TAG lipolysis. Unlike in humans and rodents, this excess energy will thus not be immediately converted to FA but into TAG and very low density lipoproteins (VLDL) in the liver [@B7]. Fatty acids may be released from chylomicrons by lipoprotein lipase (LPL) into adipose tissues, cardiac and skeletal muscle and liver. The incorporation of dietary lipids into various tissues is well-established and can be observed as a change in the relative fatty acid composition of tissues. High dietary lipid content may contribute to increased hepatic fat content and VLDL synthesis. For specific VLDL production, FAs are released from storage adipose depots by lipolysis and may be used for hepatic VLDL synthesis. Thus, *de novo* lipid synthesis and lipoprotein synthesis are functionally and anatomically separated in pigs. Moreover, during citric acid overflow, when there is excess acetyl-CoA, upon rapid mobilization of lipid stores, pig liver mitochondria release acetate instead of ketones [@B12]. The lipid metabolism of pigs is regulated by similar hormones and relevant transcription factors as in rats and humans [@B13], [@B14], but in pigs the liver has much less of a central role than in rodents, particularly when high carbohydrate diets are fed.

Lipid metabolism in ruminant animals
------------------------------------

Ruminants consume forages and cereal grains. In the forestomach fermentation system, the cell wall and soluble carbohydrates of feedstuffs are degraded and fermented into volatile fatty acids (VFA).

These fatty acids are shorter than 6 carbons long and are the principal energy source of these animals. Intake of diets containing more than 5 % fat will inhibit forestomach fermentation and are not recommended for ruminants. Consequently, exogenous FAs are less evident in ruminant tissues as compared to non-ruminants [@B15]. However, application of technology for dietary lipids exists that permits these molecules to pass the rumen and to be absorbed in the small intestine. As such, feed components escape rumen fermentation. Major sites of FA use are the mammary gland, subcutaneous adipose tissue and intramuscular lipid deposits in skeletal muscle adipocytes located in the perimysium and epimysium. The principal precursor for *de novo* FA synthesis is acetate and not glucose [@B7]; irrespective of the carbon source, almost all fatty acids are produced (except for a few resulting from lower gut digestion of microorganisms) via endogenous synthesis (DNL) in adipose and mammary glands during lactation only. The molecular regulation of DNL, lipid deposition and oxidation is affected by the same transcription factors and molecular mechanisms in both mammary tissue and subcutaneous fat stores [@B16], [@B17]. For example, during periods of rapid depot fat mobilization as often typical during the first month of lactation, hepatic accumulation of NEFA results first in ketosis followed by TAG synthesis [@B18], but the TAG is not immediately derived from lipoproteins, and TAG accumulates in the liver resulting in a adipose tissue-lipid mobilization/NEFA release-dependent fatty liver. This problem is accentuated as bovine liver has a limited capacity for NEFA oxidation. While rates of liver TAG synthesis in ruminants are similar to those of non-ruminants, hepatic VLDL secretion is very slow compared to non-ruminants [@B19]. Indeed, mechanistically hepatic steatosis in early postpartum dairy cows may be related to a lesser hepatic apoB availability [@B15], [@B20]. Ruminant species not associated with high milk production are much less likely to develop fatty livers [@B18].

**Dairy cattle.** Work on milk fat synthesis in dairy cattle has primarily centered on quantifying the relative contribution of endogenously synthesized FA (arising from lipid depots) as compared to fatty acids synthesized in the mammary. Typically, about one half of lipid of secreted milk arises from either endogenous adipose FA or dietary, rumen- protected fats, with the remainder being synthesized in the mammary tissue [@B16], [@B21]. Mammary lipid synthesis results in the production of a softer secreted fat via esterification of a mixture of short, medium and long chain FA to glycerol phosphate. More recently the role of conjugated fatty acids (CLA), arising from rumen partial hydrogenation of poly-unsaturated FA (PUFA) and subsequent animal metabolism, on total mammary fat synthesis as well as the roles of dietary and hormonal factors that influence the composition of milk fat have been widely explored [@B22].

**Beef cattle.** With beef cattle the emphasis in lipid metabolism has been on the extent of fat deposition and intramuscular lipid synthesis. Presently work is proceeding on the role of transcription factors on adipogenesis and fat synthesis in preadipocytes in muscle tissues, with both tissue culture and *in vivo* studies [@B23]. It appears that molecular regulation of preadipocyte differentiation in bovine muscle may be somewhat similar to the mechanisms described for 3T3-L1 adipocytes [@B24] in culture with key roles by CCAAT enhancer binding protein (C/EBP α,β,δ) and peroxisome proliferator-activated receptor (PPARγ) [@B1], [@B25], [@B26]. Comparative differences of beef cattle present a unique resource to study various aspects of lipid metabolism. Thus, major meat animals, both pigs and ruminants exhibit patterns of lipid metabolism distinctly different from humans and rodents.

3. Adipose depot physiology {#Section3}
===========================

Differences at a cellular, metabolic and genetic level among adipose depots have been reported in meat animals [@B1], [@B2], [@B28]. For example, subcutaneous porcine preadipocytes proliferated more actively and showed more rapid accumulation of TAG than visceral-derived adipocytes [@B29]. During differentiation, subcutaneous and visceral preadipocytes showed different, and depot-specific, effects on the expression of C/EBP, carnitine palmitoyl transferase 1B (CPT1B) and fatty acid binding protein 4 (FABP4) [@B24]. Using sheep as a model, it was determined that visceral-derived preadipocytes were less able to differentiate than subcutaneous-derived preadipocytes [@B30]. A recent study performed by Yamada et al. [@B25] in cattle demonstrated differences in the expression of the adipogenic transcription factors of the C/EPB family in subcutaneous and intramuscular adipose tissue, depending on the dietary roughage level of the feeds. Regional differences also exist in developmental morphology, cellularity, lipid content, responsiveness to metabolic regulators, and the ability to mobilize lipids in animal and tissue-specific adipose depots [@B31]-[@B33]. Moreover, adipogenesis [@B1], [@B5] inside skeletal muscle during the fetal and early postnatal stages has a dominant effect on the number of postnatal intramuscular adipocytes [@B1], [@B34], because the total number of adipocytes appears to be set when reaching adolescence in some (but not all) meat animals [@B35]. However, the mechanisms that control adipogenesis in the fetal and postnatal stages in all of the adipose depots of meat animals remain poorly defined [@B1].

Dynamics of depot adipogenesis
------------------------------

Adipose tissue is a dynamic tissue [@B1], [@B36], and from a cellular perspective adipose depot-specific hyperplasia may occur into adulthood [@B37]. A key question is where do these new adipocytes come from [@B28]? The classic view is that a majority of these cells are derived from the precursor cells in the connective tissue fraction of adipose tissue [@B38]. However, the dedifferentiation of mature adipocytes and daughter cell proliferation constitutes another significant source of new adipocytes. Adipocytes from both ruminant animals like beef cattle [@B5], [@B39]-[@B41] and monogastric animals like pigs [@B42], [@B43] possess ability to dedifferentiate [@B44], [@B39]-[@B41] and form proliferative competent progeny cells in vitro [@B39], [@B41]-[@B43]. These cells are capable of undergoing population expansion [@B41], and may re-differentiate to form lipid-filled adipocytes [@B41]-[@B43]. Classic research showed that specific numbers may be assigned to different adipose depots in beef cattle throughout postnatal aging [@B37]. Moreover, the total amount of adipose tissue (in kg) has been determined on an animal and adipose tissue depot basis [@B37]. Fernyhough et al. [@B39] proposed that 1 cell out of every 100 mature adipocytes possessed the ability to dedifferentiate and form proliferative-competent progeny cells in vitro. In the subcutaneous adipose depot of 19 month old beef steers (alone) there exists 43.2 kg of tissue and 14.306 billion cells [@B37]. Should, in fact, 1/100 mature adipocytes possess the ability to dedifferentiate and form proliferative-competent progeny cells, then approximately 100 million of the cells are potentially capable of forming new adipocytes, or other types of cells, if subjected to the appropriate physiological regulation. So, the possibility that almost every cell type in the adipocyte lineage, including mature adipocytes, are capable of proliferation and differentiation affords a great potential to very adipocyte-filled tissues, and supersedes the traditional idea that new cells added to any adipose depot are only from preadipocytes, adipofibroblasts, or (as yet) undefined stem cells residing in the depot [@B39]. This research needs to be resolved [@B45], [@B46]. Species influences on cell physiology, and depot-specific regulation differences must be included in any research design. However, the potential of outcomes of this research being applied to animal growth and development, human health and dysfunction resolution and alleviating the adverse effects of aging on body composition make the research area ripe for much participation. Indeed, the potential impact of mature adipocyte dedifferentiation in terms of cell numbers may benefit new modalities such as tissue regeneration, may change current ideas regarding postnatal stem cells, and may be useful in a variety of applications of tissue engineering [@B47].

Genetic control of different adipose depots
-------------------------------------------

The amounts of body fat stored as subcutaneous, internal, and intramuscular adipose tissue depots are quantitative traits or complex phenotypes in nature, which are generally determined by the combined effects of many loci and are affected by genetic networks or molecular pathways. A quick perusal of the Cattle QTLdb [@B48] reveals that researchers have identified quantitative trait loci (QTL) for marbling (Marb), subcutaneous adipose thickness (SAT), and kidney, heart and pelvic fat (KPH). As shown in Figure [1](#F1){ref-type="fig"}, many of these QTL have only been associated with a single adipose trait. However, there are some instances where a given QTL has been associated with two of these adipose traits (for example, compare SAT with Marb QTL on chromosome 7 in Figure [1](#F1){ref-type="fig"}). Recently, Jiang and colleagues [@B49] identified possible genetic networks that control variation for three classes of adipose tissue depots using a Wagyu x Limousin reference population (Table [2](#T2){ref-type="table"}). Subcutaneous fat depth (SFD) was measured at the 12-13^th^ rib interface perpendicular to the outside surface at a point three-fourths the length of the longissimus muscle from its chine bone end [@B49]. The internal fat depots were measured as kidney, pelvic and heart (KPH) fat percentage, which is calculated as estimated weight of KPH fat divided by hot carcass weight. The amount of fat within the muscle is known as intramuscular fat or beef marbling score (BMS), which is scored in the ribeye muscle at the 12^th^ rib based on USDA standards (<http://www.ams.usda.gov/>). The authors genotyped a total of 157 mutations, mainly single nucleotide polymorphisms derived from 82 functional genes on the animals and found 7 significant single gene-trait associations for SFD, 6 for KPH and 6 for BMS (Table [2](#T2){ref-type="table"}), but involving 16 genes. Only three genes, C-reactive protein (CRP), a regulator of calcineurin 1(RCAN1) and solute carrier family 27 (fatty acid transporter) member 2 (SLC27A2) are associated with two traits. Incorporating these single gene-trait associations for each depot into a regression model revealed a three gene *TFAM*-*BAK1*-*CAPN1* network for SFD, a three gene *CRP*-*SLC27A2-PON1* network for KPH and a two gene *RCAN1*-*CRHR1* network for BMS (Figure [2](#F2){ref-type="fig"} A, B and C), respectively [@B49]. These results indicate that subcutaneous, internal, and intramuscular adipose tissue depots may rarely share common genetic networks or genetic backgrounds (the genetic background is the same but the epigenic regulation is different among different depots).

Specific proteins produced by adipose depots
--------------------------------------------

As described above, specific genes can control and regulate adipocyte differentiation and metabolism. Through the life span of an individual, such differences may be observed, since age, nutritional input and environment factors can impact changes of gene expression. Only if there is a synthesis of functional/viable proteins for fat metabolism and development might something actually occur. To this end, it has been suggested that transcriptome expression patterns are not always correlated with the protein expression profiles, since biologically active proteins can be modified by the efficiency of translation, by post-translational modification(s), and by the rate and extent of proteolysis. Therefore, it is essential and critical to obtain and evaluate both transcriptome and proteome data sets, and (then) to use bioinformatics tools to identify protein functions and to predict the molecular mechanisms by which the proteins regulate adipogenesis and lipid metabolism. It is also increasingly recognized that post-translational modification of proteins plays an essential role in metabolism. Zhao et al. [@B50] summarized the proteome analysis on bovine subcutaneous adipose tissue from different crossbreed animals. In this study, annexin 1 was determined to be a novel protein that was expressed differentially, depending on animal breed. The annexins have functions as calcium-dependent phospholipid-binding protein that is involved in inhibition of phospholipase activity, exocytosis, endoctyosis, signal transduction, organization of the extracellular matrix, resistance to reactive oxygen species and DNA replication [@B50]. The altered protein expression of annexin 1 in animals with a higher backfat thickness suggests that the cell membrane-binding proteins may also play a role in fat depot formation in beef animals. Furthermore, in studies performed *in vitro* [@B51], a conventional proteomics approach coupled with monoclonal antibody cytokine arrays demonstrated 12 cytokines including several pro-inflamatory interleukins were secreted by neonatal preadipocytes during early adipogenesis. A number of other proteins secreted early in adipogenesis were also detected or identified with several protein assay approaches including apolipoprotein-A1, apolipoprotein-E, relaxin, brain-derived neurotrophic factor, and IGF binding protein-5 [@B51]. Several of these factors have also been identified and studied *in vivo* studies of neonatal and older pigs [@B52]. Therefore, a multifaceted approach in animal studies, clearly, can be more insightful than can *in vitro* studies of preadipocytes/cell lines alone.

4. Utilization of meat animals as models for metabolic research {#Section4}
===============================================================

The use of ruminants as models for biomedical research with adipocytes, or lipid metabolism, has been modest. Cattle are large and expensive animals to maintain. Even so, applicable research might be in mammary biology, the ontogeny of fatty livers, or the definition of adipose depot-specific regulation of lipid metabolism or adipogenesis. In addition, molecular regulation of excessive (visible) fat stores in muscle during obesity and associated maladies is difficult to study with tissue culture and cell lines. However, by using muscle biopsies sampled at various intervals during intramuscular adipose tissue development, coupled with laser dissection microscopy, adipocytes can be isolated from meat animals for transcriptomic and proteomic analyses. A potential concern to the use of farm animals as models for metabolic studies would be species-specific differences. An example of this would be the results obtained with CLAs, widely studied for their anticarcinogenic actions and potential to modify lipid deposition, but which might have different effects depending on the species. For instance, the 9-11 CLA isomer causes an inhibition of differentiation in 3T3 L1 cells [@B53], but the contrary was found in pig primary preadipocytes [@B14], showing that preadipocyte differentiation varies depending on the species of origin of the cell line or donor. In spite of these, the use of meat animals as models to test hypotheses on the accumulation of lipids in the myo- or peri-muscular cells and its association to insulin resistance can lead to a better understanding of the intramuscular fat deposition.

5. Conclusions {#Section5}
==============

Meat animals have been highly studied in order to determine ways to make them grow more efficiently (thereby saving producers money), achieve optimum consumer appeal (nutrition and health benefits), and as potential models for metabolic research (with application towards other animals and humans). Lipid metabolism (lipogenesis and lipolysis) and adipogenesis (formation of adipose tissue from precursor cells) in meat animals may/may not be similar to other animal species. As such, study of these physiological mechanisms in meat animals may produce benefits for both health and animal production disciplines.

![Comparison of identified QTL associated with SAT (A), Marb (B), and KPH (C). The red vertical lines next to each chromosome denote the location of each QTL. The results shown here are intended as a demonstration and are not intended to be comprehensive for the bovine genome.](ijbsv06p0691g01){#F1}

![Genetic networks for SFD (A), KPH (B) and BMS (C) by the linear regression analysis for all significant single gene-trait associations. The numbers in arrows represent substitution effects of one type of genotypes or allele for another one. Each combined genotype(s) among different genes has two means of performance: predicted (top or left side) and actual (bottom or right side). "-" indicates that no animals were identified with the combined genotype(s) in the population [@B49].](ijbsv06p0691g02){#F2}

###### 

Major difference in lipid metabolism between ruminant and non-ruminant animals.

                                                   Non-ruminants                                                                     Ruminants
  ------------------------------------------------ --------------------------------------------------------------------------------- -----------------------------------------------------------------------------------
  Fatty acid absorption                            Fatty acids are absorbed directly in small intestine and proceed into the blood   Fatty acids are fermented into volatile fatty acids in rumen, which are absorbed.
  Principal site of fatty acid de novo synthesis   Liver (humans; rodents) Adipose (pigs)                                            Adipose tissue, as well as mammary gland for lactating ruminants
  Precursor for fatty acid de novo synthesis       Glucose                                                                           Acetate
  Fatty acids in circulation                       Very low density lipoproteins and chylomicrons                                    Volatile fatty acids and low density lipoproteins
  Fatty acid composition                           Long chain fatty acids with a sizeable proportion of unsaturated fatty acids      High proportion of short chain saturated fatty acids

###### 

Functional genes associated with subcutaneous (SAT), internal (KPH) or intramuscular adipose tissue (Marb) depots discovered in a Wagyu x Limousin reference population [@B49]\*.

  Symbol            Description                                                             SFD     KPH   BMS
  ----------------- ----------------------------------------------------------------------- ------- ----- -----
  ABCA1 APOE BAK1   ATP binding cassette A1 Apolipoprotein E BCL2-antagonist/killer 1       A D A         
  CAPN1             Calpain 1                                                               A             
  CRHR1             Corticotropin releasing hormone receptor 1                                            A
  CRP               C-reactive protein, pentraxin-related                                           D     D
  DHCR7             7-dehydrocholesterol reductase                                                        O
  FABP4             Fatty acid binding protein 4                                                    O     
  PAPD1             Poly (A) polymerase associated domain containing 1                              O     
  RCAN1             Regulator of calcineurin 1                                                      D     A
  PON1 SKIV2L       Paraoxidase I Superkiller viralicidic activity 2-like (S. cerevisiae)   A       D     
  SLC27A2           Solute carrier family 27, member 2                                      A       D     
  TFAM              Transcription factor A, mitochondrial                                   A             
  TFBM1             Transcription factor B1, mitochondrial                                                A
  UCN3              Urocortin 3                                                                           O

\*Only significant associations (P\<0.05) were presented for each gene with additive (A), dominant (D) and overdominant (O) effects.
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